Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Cancer survival comes at its own price

Cancer survival comes at its own price

High-dose radiation and bone marrow transfer treatments on glaucoma-susceptible mice completely blocked development of glaucoma

High-dose radiation and bone marrow transfer treatments on glaucoma-susceptible mice completely blocked development of glaucoma

Inherited traits and tumor mutations affect response to treatment of leukemia

Inherited traits and tumor mutations affect response to treatment of leukemia

Older women benefit from chemo to treat breast cancer

Older women benefit from chemo to treat breast cancer

U.S. cancer researchers launch first American-Israeli cancer conference

U.S. cancer researchers launch first American-Israeli cancer conference

Experts on chronic lymphocytic leukemia (CLL) review current scientific knowledge

Experts on chronic lymphocytic leukemia (CLL) review current scientific knowledge

Sir Bobby Robson opens state-of-the-art research centre

Sir Bobby Robson opens state-of-the-art research centre

Feverfew or Bachelor's Button, kills human leukemia stem cells like no other single therapy

Feverfew or Bachelor's Button, kills human leukemia stem cells like no other single therapy

Association noted between certain non-lver cancers and hepatitis C

Association noted between certain non-lver cancers and hepatitis C

Why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa)

Why some lung cancers stop responding to the drugs erlotinib (Tarceva) and gefitinib (Iressa)

New compound, AMN107, 20 times more potent than Gleevec for chronic myelogenous leukemia treatment

New compound, AMN107, 20 times more potent than Gleevec for chronic myelogenous leukemia treatment

Vaccine that boosts the immune response could improve the effect of conventional treatment for patients with chronic myeloid leukaemia

Vaccine that boosts the immune response could improve the effect of conventional treatment for patients with chronic myeloid leukaemia

Better understanding of cell signalling helps cancer research

Better understanding of cell signalling helps cancer research

Exposure of expectant mothers to urban air pollution may alter the structure of babies' chromosomes while in the womb

Exposure of expectant mothers to urban air pollution may alter the structure of babies' chromosomes while in the womb

New compound AMN107 may help treat some imatinib resistant cancer cases

New compound AMN107 may help treat some imatinib resistant cancer cases

Experimental drug Revlimid showing promise as treatment for myelodysplastic syndrome (MDS)

Experimental drug Revlimid showing promise as treatment for myelodysplastic syndrome (MDS)

Artemisinin could selectively kill cancer cells while leaving normal cells unharmed

Artemisinin could selectively kill cancer cells while leaving normal cells unharmed

Level of immune cell DNA in the blood might help predict success of stem cell transplantation

Level of immune cell DNA in the blood might help predict success of stem cell transplantation

Cell research signals cancer hope

Cell research signals cancer hope

Gene used in brain development can cause childhood brain cancers

Gene used in brain development can cause childhood brain cancers